Si-Bone (SIBN) Preferred Stock Liabilities (2017 - 2018)
Si-Bone (SIBN) recorded quarterly Preferred Stock Liabilities of $118.5 million in Q3 2018, little changed quarter-over-quarter from $118.5 million in Q4 2017.
Si-Bone (SIBN) Preferred Stock Liabilities (2017 - 2018) Analysis & Trends
Si-Bone's Preferred Stock Liabilities history runs 2 years deep, the most recent figure standing at $118.5 million for Q3 2018.
- In Q3 2018, Preferred Stock Liabilities changed N/A year-over-year to $118.5 million; the TTM figure through Sep 2018 stood at $118.5 million (changed N/A YoY), while the FY2017 annual figure was $118.5 million, changed N/A from the prior year.
- Preferred Stock Liabilities was $118.5 million for Q3 2018 at Si-Bone, roughly flat from $118.5 million in the prior quarter.
- In the past five years, Preferred Stock Liabilities ranged from a high of $118.5 million in Q4 2017 to a low of $118.5 million in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Si-Bone | 696.98 Mn | 556.86 Mn | 41.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 118.55 Mn |
| Dec 31, 2017 | 118.55 Mn |